222 related articles for article (PubMed ID: 17127278)
1. Role of TWEAK and Fn14 in tumor biology.
Winkles JA; Tran NL; Brown SA; Stains N; Cunliffe HE; Berens ME
Front Biosci; 2007 Jan; 12():2761-71. PubMed ID: 17127278
[TBL] [Abstract][Full Text] [Related]
2. TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.
Blanco-Colio LM; Martín-Ventura JL; Munoz-Garcia B; Moreno JA; Meilhac O; Ortiz A; Egido J
Front Biosci; 2007 May; 12():3648-55. PubMed ID: 17485328
[TBL] [Abstract][Full Text] [Related]
3. TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
Brown SA; Hanscom HN; Vu H; Brew SA; Winkles JA
Biochem J; 2006 Jul; 397(2):297-304. PubMed ID: 16526941
[TBL] [Abstract][Full Text] [Related]
4. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
5. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
Wiley SR; Winkles JA
Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
[TBL] [Abstract][Full Text] [Related]
6. Tweak and FN14 in central nervous system health and disease.
Yepes M
Front Biosci; 2007 May; 12():2772-81. PubMed ID: 17485258
[TBL] [Abstract][Full Text] [Related]
7. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
8. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.
Jain M; Jakubowski A; Cui L; Shi J; Su L; Bauer M; Guan J; Lim CC; Naito Y; Thompson JS; Sam F; Ambrose C; Parr M; Crowell T; Lincecum JM; Wang MZ; Hsu YM; Zheng TS; Michaelson JS; Liao R; Burkly LC
Circulation; 2009 Apr; 119(15):2058-68. PubMed ID: 19349318
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.
Zhu LX; Zhang HH; Mei YF; Zhao YP; Zhang ZY
Chin Med J (Engl); 2012 Nov; 125(21):3898-904. PubMed ID: 23106895
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
[TBL] [Abstract][Full Text] [Related]
11. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
[TBL] [Abstract][Full Text] [Related]
12. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
[TBL] [Abstract][Full Text] [Related]
13. No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies.
Zheng TS; Burkly LC
J Leukoc Biol; 2008 Aug; 84(2):338-47. PubMed ID: 18483204
[TBL] [Abstract][Full Text] [Related]
14. TWEAK-Fn14 as a mediator of acute kidney injury.
Weinberg JM
Kidney Int; 2011 Jan; 79(2):151-3. PubMed ID: 21191390
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
16. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
17. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
18. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
Campbell S; Michaelson J; Burkly L; Putterman C
Front Biosci; 2004 Sep; 9():2273-84. PubMed ID: 15353286
[TBL] [Abstract][Full Text] [Related]
19. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
